Head and Neck Diseases by Alexandros G.Sfakianakis: Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Σάββατο 8 Απριλίου 2017

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal.

Acta Oncol. 2017 Apr 07;:1-3

Authors: Lubberman FJ, van Erp NP, Ter Heine R, van Herpen CM

PMID: 28388255 [PubMed - as supplied by publisher]

http://ift.tt/2o9frYy

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Εγγραφή σε: Σχόλια ανάρτησης (Atom)